SK286676B6 - Použitie ftalazínových derivátov - Google Patents
Použitie ftalazínových derivátov Download PDFInfo
- Publication number
- SK286676B6 SK286676B6 SK1595-2001A SK15952001A SK286676B6 SK 286676 B6 SK286676 B6 SK 286676B6 SK 15952001 A SK15952001 A SK 15952001A SK 286676 B6 SK286676 B6 SK 286676B6
- Authority
- SK
- Slovakia
- Prior art keywords
- alkyl
- treatment
- hydrogen
- parp
- damage
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Communicable Diseases (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Psychiatry (AREA)
- Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19921567A DE19921567A1 (de) | 1999-05-11 | 1999-05-11 | Verwendung von Phthalazine-Derivaten |
PCT/EP2000/003967 WO2000067734A2 (de) | 1999-05-11 | 2000-05-03 | Verwendung von phthalazine-derivaten |
Publications (2)
Publication Number | Publication Date |
---|---|
SK15952001A3 SK15952001A3 (sk) | 2002-08-06 |
SK286676B6 true SK286676B6 (sk) | 2009-03-05 |
Family
ID=7907632
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1595-2001A SK286676B6 (sk) | 1999-05-11 | 2000-05-03 | Použitie ftalazínových derivátov |
Country Status (20)
Country | Link |
---|---|
US (1) | US6903098B1 (ko) |
EP (1) | EP1231982B1 (ko) |
JP (1) | JP2003502286A (ko) |
KR (1) | KR20020000642A (ko) |
CN (1) | CN1399573A (ko) |
AT (1) | ATE357272T1 (ko) |
AU (1) | AU5064000A (ko) |
BG (1) | BG106056A (ko) |
BR (1) | BR0010428A (ko) |
CA (1) | CA2372704A1 (ko) |
CZ (1) | CZ20014038A3 (ko) |
DE (2) | DE19921567A1 (ko) |
ES (1) | ES2284499T3 (ko) |
HU (1) | HUP0202477A3 (ko) |
IL (1) | IL146148A0 (ko) |
NO (1) | NO20015462L (ko) |
PL (1) | PL352150A1 (ko) |
SK (1) | SK286676B6 (ko) |
TR (1) | TR200103236T2 (ko) |
WO (1) | WO2000067734A2 (ko) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU7989400A (en) | 1999-10-01 | 2001-05-10 | Smithkline Beecham Corporation | Compounds and methods |
NZ521792A (en) * | 2000-03-20 | 2004-06-25 | N Gene Res Lab Inc | Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and use in treating conditions connected with oxygen deficiency |
US7151102B2 (en) | 2000-10-30 | 2006-12-19 | Kudos Pharmaceuticals Limited | Phthalazinone derivatives |
US6924284B2 (en) * | 2001-08-15 | 2005-08-02 | Icos Corporation | PARP inhibitors |
US7196085B2 (en) | 2002-04-30 | 2007-03-27 | Kudos Pharmaceuticals Limited | Phthalazinone derivatives |
ATE405658T1 (de) | 2002-07-26 | 2008-09-15 | Basf Plant Science Gmbh | Neue selektionsverfahren |
KR100735781B1 (ko) | 2002-10-01 | 2007-07-06 | 미쯔비시 웰 파마 가부시키가이샤 | 이소퀴놀린 화합물 및 그의 의약 용도 |
ES2376166T3 (es) | 2002-11-22 | 2012-03-09 | Mitsubishi Tanabe Pharma Corporation | Compuestos de isoquinolina y su uso medicinal. |
GB0305681D0 (en) | 2003-03-12 | 2003-04-16 | Kudos Pharm Ltd | Phthalazinone derivatives |
US7449464B2 (en) | 2003-03-12 | 2008-11-11 | Kudos Pharmaceuticals Limited | Phthalazinone derivatives |
CA2599405A1 (en) | 2005-03-08 | 2006-09-14 | Basf Plant Science Gmbh | Expression enhancing intron sequences |
ZA200800907B (en) * | 2005-07-18 | 2010-04-28 | Bipar Sciences Inc | Treatment of cancer |
GB0521373D0 (en) | 2005-10-20 | 2005-11-30 | Kudos Pharm Ltd | Pthalazinone derivatives |
US20080262062A1 (en) * | 2006-11-20 | 2008-10-23 | Bipar Sciences, Inc. | Method of treating diseases with parp inhibitors |
JP2010504079A (ja) * | 2006-06-12 | 2010-02-12 | バイパー サイエンシズ,インコーポレイティド | Parp阻害剤を用いる疾病の治療方法 |
US20100279327A1 (en) * | 2006-06-12 | 2010-11-04 | Bipar Sciences, Inc. | Method of treating diseases with parp inhibitors |
WO2008030883A2 (en) * | 2006-09-05 | 2008-03-13 | Bipar Sciences, Inc. | Treatment of cancer |
CN101534836B (zh) * | 2006-09-05 | 2011-09-28 | 彼帕科学公司 | Parp抑制剂在制备治疗肥胖症的药物中的用途 |
UY30639A1 (es) | 2006-10-17 | 2008-05-31 | Kudos Pharm Ltd | Derivados sustituidos de 2h-ftalazin-1-ona, sus formas cristalinas, proceso de preparacion y aplicaciones |
RS53196B (en) * | 2006-12-28 | 2014-06-30 | Abbvie Inc. | INHIBITORI POLI (ADP-RIBOZA) POLIMERAZE |
US8466150B2 (en) * | 2006-12-28 | 2013-06-18 | Abbott Laboratories | Inhibitors of poly(ADP-ribose)polymerase |
US20090023727A1 (en) * | 2007-07-05 | 2009-01-22 | Muhammad Hashim Javaid | Phthalazinone derivatives |
RU2010108008A (ru) | 2007-09-14 | 2011-10-20 | Астразенека Аб (Se) | Фталазиноновые производные |
MX2010005221A (es) * | 2007-11-12 | 2010-09-28 | Bipar Sciences Inc | Tratamiento de cancer de utero y cancer de ovario con un inhibidor de parp solo o en combinacion con agentes antitumorales. |
CN103169973A (zh) * | 2007-11-12 | 2013-06-26 | 彼帕科学公司 | 使用4-碘-3-硝基苯甲酰胺化合物与抗肿瘤剂组合治疗乳腺癌 |
RU2010128107A (ru) * | 2007-12-07 | 2012-01-20 | Байпар Сайенсиз, Инк. (Us) | Лечение рака ингибиторами топоизомеразы в комбинации с ингибиторами parp |
AR070221A1 (es) | 2008-01-23 | 2010-03-25 | Astrazeneca Ab | Derivados de ftalazinona inhibidores de polimerasas, composiciones farmaceuticas que los contienen y usos de los mismos para prevenir y/o tratar tumores cancerigenos,lesiones isquemicas y otras enfermedades asociadas. |
MX2010008572A (es) * | 2008-02-04 | 2010-11-30 | Bipar Sciences Inc | Metodos de diagnostico y tratamiento de enfermedades mediadas por poli(adp-ribosa) polimerasa. |
US8012976B2 (en) | 2008-08-06 | 2011-09-06 | Biomarin Pharmaceutical Inc. | Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) |
CN102238945B (zh) | 2008-10-07 | 2014-10-29 | 阿斯利康(英国)有限公司 | 药物制剂514 |
US20120324603A1 (en) | 2009-11-27 | 2012-12-20 | BASF Plant Sceience Company GmbH | Chimeric Endonucleases and Uses Thereof |
AU2010325549B2 (en) | 2009-11-27 | 2017-04-20 | Basf Plant Science Company Gmbh | Optimized endonucleases and uses thereof |
DE112010004583T5 (de) | 2009-11-27 | 2012-10-18 | Basf Plant Science Company Gmbh | Chimäre Endonukleasen und Anwendungen davon |
CN102869258A (zh) | 2010-02-03 | 2013-01-09 | 生物马林药物股份有限公司 | 用于pten基因缺失相关疾病的治疗的聚(adp-核糖)聚合酶(parp)的二氢吡啶并酞嗪酮抑制剂 |
PT2533640T (pt) * | 2010-02-08 | 2017-01-03 | Medivation Technologies Inc | Processos de síntese de derivados de di-hidropiridoftalazinona |
AU2011251622A1 (en) | 2010-05-10 | 2012-12-20 | Radikal Therapeutics Inc. | Lipoic acid and nitroxide derivatives and uses thereof |
TWI557123B (zh) | 2010-10-21 | 2016-11-11 | 梅迪維新技術公司 | 結晶型(8S,9R)-5-氟-8-(4-氟苯基)-9-(1-甲基-1H-1,2,4-三唑-5-基)-8,9-二氫-2H-吡啶并[4,3,2-de]呔-3(7H)-酮甲苯磺酸鹽 |
US9649394B2 (en) | 2010-11-22 | 2017-05-16 | The General Hospital Corporation | Compositions and methods for in vivo imaging |
CN103130723B (zh) * | 2011-11-30 | 2015-01-14 | 成都地奥制药集团有限公司 | 一种多聚(adp-核糖)聚合酶抑制剂 |
CN103325380B (zh) | 2012-03-23 | 2017-09-12 | 杜比实验室特许公司 | 用于信号增强的增益后处理 |
US10722484B2 (en) | 2016-03-09 | 2020-07-28 | K-Gen, Inc. | Methods of cancer treatment |
US10874641B2 (en) | 2016-07-28 | 2020-12-29 | Mitobridge, Inc. | Methods of treating acute kidney injury |
EP3534957A1 (en) | 2016-11-02 | 2019-09-11 | Immunogen, Inc. | Combination treatment with antibody-drug conjugates and parp inhibitors |
WO2023020457A1 (en) * | 2021-08-17 | 2023-02-23 | InventisBio Co., Ltd. | Pyridazinone or pyridinone compounds, preparation methods and uses thereof |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58116471A (ja) | 1981-12-29 | 1983-07-11 | Nippon Kayaku Co Ltd | 4−ヒドロキシメチル−1−フタラゾンエステル誘導体およびその塩 |
US4939140A (en) * | 1985-11-07 | 1990-07-03 | Pfizer Inc. | Heterocyclic oxophthalazinyl acetic acids |
NZ290952A (en) * | 1994-08-09 | 1998-05-27 | Eisai Co Ltd | Phthalazine derivatives optionally substituted in position-1 by (generally benzyl) amino groups |
US6635642B1 (en) | 1997-09-03 | 2003-10-21 | Guilford Pharmaceuticals Inc. | PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same |
ATE212991T1 (de) | 1997-12-02 | 2002-02-15 | Reddy Research Foundation | Thiazolidinedione- und oxazolidinedione-derivate mit antidiabetischen, hypolipidämischen und anti hypertensiven eigenschaften |
CO5070700A1 (es) | 1998-06-05 | 2001-08-28 | Basf Ag | Genes novedosos de (adp-ribosa) polimerasa |
ITMI981671A1 (it) * | 1998-07-21 | 2000-01-21 | Zambon Spa | Derivati ftalazinici inibitori della fosfodisterasi 4 |
ITMI981670A1 (it) * | 1998-07-21 | 2000-01-21 | Zambon Spa | Derivati ftalazinici inibitori della fosfodiesterasi 4 |
-
1999
- 1999-05-11 DE DE19921567A patent/DE19921567A1/de not_active Withdrawn
-
2000
- 2000-05-03 PL PL00352150A patent/PL352150A1/xx not_active Application Discontinuation
- 2000-05-03 SK SK1595-2001A patent/SK286676B6/sk not_active IP Right Cessation
- 2000-05-03 AU AU50640/00A patent/AU5064000A/en not_active Abandoned
- 2000-05-03 DE DE50014190T patent/DE50014190D1/de not_active Expired - Lifetime
- 2000-05-03 BR BR0010428-0A patent/BR0010428A/pt not_active IP Right Cessation
- 2000-05-03 WO PCT/EP2000/003967 patent/WO2000067734A2/de not_active Application Discontinuation
- 2000-05-03 CZ CZ20014038A patent/CZ20014038A3/cs unknown
- 2000-05-03 TR TR2001/03236T patent/TR200103236T2/xx unknown
- 2000-05-03 EP EP00934980A patent/EP1231982B1/de not_active Expired - Lifetime
- 2000-05-03 IL IL14614800A patent/IL146148A0/xx unknown
- 2000-05-03 CN CN00808074A patent/CN1399573A/zh active Pending
- 2000-05-03 HU HU0202477A patent/HUP0202477A3/hu unknown
- 2000-05-03 CA CA002372704A patent/CA2372704A1/en not_active Abandoned
- 2000-05-03 US US09/959,404 patent/US6903098B1/en not_active Expired - Fee Related
- 2000-05-03 JP JP2000616761A patent/JP2003502286A/ja active Pending
- 2000-05-03 AT AT00934980T patent/ATE357272T1/de not_active IP Right Cessation
- 2000-05-03 KR KR1020017014342A patent/KR20020000642A/ko not_active Application Discontinuation
- 2000-05-03 ES ES00934980T patent/ES2284499T3/es not_active Expired - Lifetime
-
2001
- 2001-10-26 BG BG106056A patent/BG106056A/xx unknown
- 2001-11-08 NO NO20015462A patent/NO20015462L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HUP0202477A3 (en) | 2003-02-28 |
PL352150A1 (en) | 2003-07-28 |
DE50014190D1 (de) | 2007-05-03 |
EP1231982B1 (de) | 2007-03-21 |
BG106056A (en) | 2002-06-28 |
IL146148A0 (en) | 2002-07-25 |
SK15952001A3 (sk) | 2002-08-06 |
CA2372704A1 (en) | 2000-11-16 |
US6903098B1 (en) | 2005-06-07 |
NO20015462D0 (no) | 2001-11-08 |
JP2003502286A (ja) | 2003-01-21 |
DE19921567A1 (de) | 2000-11-16 |
ATE357272T1 (de) | 2007-04-15 |
ES2284499T3 (es) | 2007-11-16 |
CZ20014038A3 (cs) | 2002-06-12 |
WO2000067734A2 (de) | 2000-11-16 |
KR20020000642A (ko) | 2002-01-05 |
BR0010428A (pt) | 2002-04-30 |
CN1399573A (zh) | 2003-02-26 |
TR200103236T2 (tr) | 2004-08-23 |
NO20015462L (no) | 2001-11-08 |
AU5064000A (en) | 2000-11-21 |
EP1231982A2 (de) | 2002-08-21 |
HUP0202477A2 (hu) | 2002-12-28 |
WO2000067734A3 (de) | 2002-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK286676B6 (sk) | Použitie ftalazínových derivátov | |
US7087637B2 (en) | Substituted indoles which are PARP inhibitors | |
US6448271B1 (en) | Substituted benzimidazoles and their use as parp inhibitors | |
US6737421B1 (en) | Cyclo-alkyl substituted benzimidazoles and their use as PARP inhibitors | |
SK6742001A3 (en) | 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof | |
JP2003510328A (ja) | アゼピノインドール誘導体、その製法ならびに使用 | |
KR101009554B1 (ko) | Pde7 억제제로서 스피로시클릭 퀴나졸린 유도체 | |
SK5952001A3 (en) | Substituted 2-phenylbenzimidazoles, the production thereof and their use | |
EA008241B1 (ru) | Ингибиторы фосфатидилинозитол-3-киназы дельта человека | |
WO2021136463A1 (zh) | 嘌呤衍生物及其在医药上的用途 | |
US8835445B2 (en) | Dihydrofolate reductase inhibitors | |
WO2011135303A2 (en) | Ubiquitination modulators | |
EA028673B1 (ru) | ПИРИМИДО[4,5-b]ХИНОЛИН-4,5(3H,10H)ДИОНЫ В КАЧЕСТВЕ СУПРЕССОРОВ НОНСЕНС МУТАЦИЙ | |
US20040192914A1 (en) | Compounds and methods | |
CA2813743C (en) | Selective proton coupled folate transporter and folate receptor, and garftase and/or other folate metabolizing enzymes inhibitor compounds and methods of using the same | |
US7026311B2 (en) | Dibenzodiazepine derivatives, their preparation and use | |
JP3858279B2 (ja) | トロンボキサンa2関与疾患の予防・治療剤 | |
MXPA01011330A (en) | Use of phthalazine derivatives | |
US6858617B2 (en) | Substituted imidazole compounds | |
US6492550B2 (en) | Alpha-substituted thio, -oxo trifluoromethylketones as phospholipase inhibitors | |
WO2023131677A1 (en) | Compounds containing a hydroxyphenyl moiety and their use | |
MXPA01005199A (en) | Azepinoindole derivatives, the production and use thereof | |
MXPA01010673A (es) | Benzimidazoles ciclo-alquil substituidos y su uso como inhibidores parp |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC4A | Assignment and transfer of rights |
Owner name: ABBVIE DEUTSCHLAND GMBH & CO. KG, WIESBADEN, DE Free format text: FORMER OWNER: ABBOTT GMBH & CO. KG, WIESBADEN, DE Effective date: 20150904 Owner name: GOLIATH HUNDERZEHNTE VERMOEGENSVERWALTUNGSSGES, DE Free format text: FORMER OWNER: BASF AKTIENGESELLSCHAFT, LUDWIGSHAFEN, DE Effective date: 20150904 Owner name: ABBOTT GMBH, WIESBADEN, DE Free format text: FORMER OWNER: ABBOTT DEUTSCHLAND HOLDING GMBH, WIESBADEN, DE Effective date: 20150904 Owner name: ABBOTT GMBH & CO. KG, WIESBADEN, DE Free format text: FORMER OWNER: ABBOTT GMBH, WIESBADEN, DE Effective date: 20150904 |
|
TC4A | Change of owner's name |
Owner name: ABBOTT DEUTSCHLAND HOLDING GMBH, WIESBADEN, DE Effective date: 20150904 |
|
MM4A | Patent lapsed due to non-payment of maintenance fees |
Effective date: 20170503 |